Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › Coronavirus Tests From Fosun Pharma, Osang Healthcare Receive FDA Emergency Use Authorization

Coronavirus Tests From Fosun Pharma, Osang Healthcare Receive FDA Emergency Use Authorization

Apr 20, 2020
|
staff reporter

NEW YORK ─ The US Food and Drug Administration has granted Emergency Use Authorization to Shanghai Fosun Pharmaceutical for its COVID-19 RT-PCR detection kit and Osang Healthcare for its GeneFinder COVID-19 Plus RealAmp Kit.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

    Premium

  2. JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

  3. Report Details COVID-19 Testing Within Federal Government

  4. JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

  5. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.